Intervention type

Phase

Drug names

Primary outcome measures

Secondary outcome measures

Not provided at time of registration

Overall trial start date

01/01/2003

Overall trial end date

30/06/2003

Reason abandoned

Eligibility

Participant inclusion criteria

Candidates who stated they were healthy, non-smoking, age 21-35 years, within 30% of ideal body weight and had normal sleeping habits were scheduled for a screening interview. Urine pregnancy tests were performed to ensure that female subjects were not pregnant. Subjects were asked to avoid depressants including ethanol (confirmed by measuring exhaled ethanol) and stimulants for 24 hours before study sessions. Subjects were formally admitted to the study if, after sleep latency testing, their average sleep latency was 10 min and they had no onsets of rapid eye movement (REM) sleep, which is indicative of narcolepsy.

Sponsor details

Sponsor type

Website

Funders

Funder type

Research organisation

Funder name

NIH (GCRC at the University of Chicago, funded by grant number M01 RR00055 from the National Center for Research Resources of the National Institutes of Health) and the Department of Anesthesia, University of Chicago